相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions
Elisabetta Pace et al.
EUROPEAN JOURNAL OF CANCER (2011)
IL-15 induces CD8+T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion
Margareta P. Correia et al.
IMMUNOBIOLOGY (2011)
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
Marloes Gooden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Immunoregulatory Role of CD244 in Chronic Hepatitis B Infection and its Inhibitory Potential on Virus-Specific CD8+T-cell Function
Bijan Raziorrouh et al.
HEPATOLOGY (2010)
HLA-E restricted regulatory CD8+ T cells are involved in development and control of human autoimmune type 1 diabetes
Hong Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Harnessing the immune response to treat cancer
H. J. Steer et al.
ONCOGENE (2010)
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
Tadepally Lakshmikanth et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1
Gili G. Halfteck et al.
JOURNAL OF IMMUNOLOGY (2009)
A Worldwide Approach to the TNM Staging System: Collaborative Efforts of the AJCC and UICC
Frederick L. Greene et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125)
Jennifer A. Belisle et al.
IMMUNOLOGY (2007)
Cutting edge: Distinct NK receptor profiles are imprinted on CD8 T cells in the mucosa and periphery during the same antigen challenge: Role of tissue-specific factors
Amale Laouar et al.
JOURNAL OF IMMUNOLOGY (2007)
The CD94/NKG2 family of receptors - From molecules and cells to clinical relevance
Francisco Borrego et al.
IMMUNOLOGIC RESEARCH (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse
Madhan Masilamani et al.
JOURNAL OF IMMUNOLOGY (2006)
Expression and release of HLA-E by melanoma cells and melanocytes: Potential impact on the response of cytotoxic effector cells
Laurent Derre et al.
JOURNAL OF IMMUNOLOGY (2006)
Surface NK receptors and their ligands on tumor cells
Lorenzo Moretta et al.
SEMINARS IN IMMUNOLOGY (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125
MS Patankar et al.
GYNECOLOGIC ONCOLOGY (2005)
HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: Implications for immune escape in vivo
J Wischhusen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma
BC Sheu et al.
CANCER RESEARCH (2005)
2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells
ME McNerney et al.
MOLECULAR IMMUNOLOGY (2005)
Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar typhi strain Ty21a typhoid vaccine
R Salerno-Gonçalves et al.
JOURNAL OF IMMUNOLOGY (2004)
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes
G Pietra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis
M Guidoboni et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
A fresh look at tumor immunosurveillance and immunotherapy
MJ Smyth et al.
NATURE IMMUNOLOGY (2001)